Arkfeld Wealth Strategies’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$471K Sell
3,716
-33
-0.9% -$3.86K 0.14% 72
2026
Q1
$442K Buy
3,749
+1,058
+39% +$122K 0.14% 71
2025
Q4
$292K Buy
2,691
+4
+0.1% +$375 0.1% 85
2025
Q3
$240K Sell
2,687
-23
-0.8% -$1.89K 0.09% 96
2025
Q2
$219K Hold
2,710
0.09% 100
2025
Q1
$222K Buy
2,710
+4
+0.1% +$373 0.1% 90
2024
Q4
$273K Buy
2,706
+7
+0.3% +$722 0.13% 79
2024
Q3
$296K Hold
2,699
0.14% 78
2024
Q2
$340K Buy
2,699
+2
+0.1% +$258 0.17% 75
2024
Q1
$342K Buy
2,697
+3
+0.1% +$370 0.19% 71
2023
Q4
$319K Buy
2,694
+407
+18% +$42.2K 0.21% 61
2023
Q3
$237K Buy
2,287
+3
+0.1% +$323 0.17% 70
2023
Q2
$245K Buy
2,284
+112
+5% +$12.7K 0.18% 68
2023
Q1
$244K Buy
2,172
+2
+0.1% +$216 0.17% 64
2022
Q4
$240K Buy
+2,170
New +$222K 0.16% 65
2022
Q3
Sell
-2,164
Closed -$201K 70
2022
Q2
$201K Buy
+2,164
New +$192K 0.13% 67

Other funds holding MRK

Arkfeld Wealth Strategies's MRK Position: Q2 2026 in Review

Arkfeld Wealth Strategies reduced its Merck (MRK) stake by 0.88% in Q2 2026, selling an estimated $3.86K and leaving 3,716 shares worth $471K. The position accounts for 0.14% of the portfolio, ranked #72.

Arkfeld Wealth Strategies first reported a position in MRK in Q2 2022 and has held it in 16 quarters since. 3,820 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Arkfeld Wealth Strategies held 3,716 shares of Merck worth $471K as of Q2 2026.
  • Arkfeld Wealth Strategies sold 33 Merck shares in Q2 2026, an estimated $3.86K.
  • Merck made up 0.14% of Arkfeld Wealth Strategies's portfolio in Q2 2026, its #72 holding.
  • Arkfeld Wealth Strategies first reported a position in Merck in Q2 2022 and has held it in 16 quarters since.
  • 3,820 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Arkfeld Wealth Strategies's 13F filing for Q2 2026, filed 10 Jul 2026.